CloudCath
Pre-clinicalCloudCath quantifies peritoneal dialysis fluid turbidity, identifying potential infections 3.1 days before patient-reported symptoms leading to:
Founded
2017
Focus
Medical DevicesDigital Health
About
CloudCath quantifies peritoneal dialysis fluid turbidity, identifying potential infections 3.1 days before patient-reported symptoms leading to:
Funding History
2Total raised: $11.5M
Series A$10MUndisclosedFeb 15, 2021
Seed$1.5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2017
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile